| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 464 | 2020 |
| Combined landscape of single-nucleotide variants and copy-number alterations in clonal hematopoiesis R Saiki, Y Momozawa, Y Nannya, MM Nakagawa, Y Ochi, T Yoshizato, ... Nature medicine, 2021 | 92 | 2021 |
| Germ line DDX41 mutations define a unique subtype of myeloid neoplasms H Makishima, R Saiki, Y Nannya, S Korotev, C Gurnari, J Takeda, ... Blood 141 (5), 534-549, 2023 | 67 | 2023 |
| Combined Cohesin–RUNX1 deficiency synergistically perturbs chromatin looping and causes myelodysplastic syndromes Y Ochi, A Kon, T Sakata, MM Nakagawa, N Nakazawa, M Kakuta, ... Cancer discovery 10 (6), 836-853, 2020 | 62 | 2020 |
| DOCK2 is involved in the host genetics and biology of severe COVID-19 H Namkoong, R Edahiro, T Takano, H Nishihara, Y Shirai, K Sonehara, ... Nature 609 (7928), 754-760, 2022 | 53 | 2022 |
| Unbiased detection of driver mutations in extramammary Paget disease Y Ishida, N Kakiuchi, K Yoshida, Y Inoue, H Irie, TR Kataoka, M Hirata, ... Clinical Cancer Research 27 (6), 1756-1765, 2021 | 31 | 2021 |
| Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial CM Arends, S Dimitriou, A Stahler, R Hablesreiter, PM Strzelecka, ... Blood, The Journal of the American Society of Hematology 139 (10), 1593-1597, 2022 | 24 | 2022 |
| Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID‐19: Integrative analysis from the Japan COVID‐19 task force T Fukushima, S Chubachi, H Namkoong, T Asakura, H Tanaka, H Lee, ... Diabetes, Obesity and Metabolism 25 (1), 144-155, 2023 | 16 | 2023 |
| Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia J Takeda, K Yoshida, MM Nakagawa, Y Nannya, A Yoda, R Saiki, Y Ochi, ... Blood cancer discovery 3 (5), 410-427, 2022 | 16 | 2022 |
| Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status R Shrestha, M Sakata-Yanagimoto, K Maie, M Oshima, M Ishihara, ... Blood advances 4 (5), 845-854, 2020 | 15 | 2020 |
| Evolutionary histories of breast cancer and related clones T Nishimura, N Kakiuchi, K Yoshida, T Sakurai, TR Kataoka, E Kondoh, ... Nature 620 (7974), 607-614, 2023 | 14 | 2023 |
| The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force QS Wang, R Edahiro, H Namkoong, T Hasegawa, Y Shirai, K Sonehara, ... Nature communications 13 (1), 4830, 2022 | 14 | 2022 |
| Clonal evidence for the development of neuroblastoma with extensive copy‐neutral loss of heterozygosity arising in a mature teratoma R Ono, H Ueno, K Yoshida, S Takahashi, H Yoshihara, T Nozaki, ... Cancer science 112 (7), 2921-2927, 2021 | 2 | 2021 |
| Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms T Sato, K Yoshida, T Toki, R Kanezaki, K Terui, R Saiki, M Ojima, Y Ochi, ... Blood, 2024 | | 2024 |
| Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Evolves from TP53-Mutated Clonal Hematopoiesis R Saiki, S Ogawa Blood Cancer Discovery 4 (2), 102-105, 2023 | | 2023 |
